Skip Navigation


NDT Advance Access originally published online on November 9, 2005
Nephrology Dialysis Transplantation 2006 21(1):16-20; doi:10.1093/ndt/gfi265
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/1/16    most recent
gfi265v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ruiz-Ortega, M.
Right arrow Articles by Egido, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz-Ortega, M.
Right arrow Articles by Egido, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Editorial Comment

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

Marta Ruiz-Ortega, Mónica Rupérez, Vanesa Esteban, Juan Rodríguez-Vita, Elsa Sánchez-López, Giselle Carvajal and Jesús Egido

Vascular and Renal Research Laboratory, Fundación Jiménez Diaz, Universidad Autónoma Madrid, Spain

Correspondence and offprint requests to: Marta Ruiz-Ortega, Vascular and Renal Research Laboratory, Fundación Jiménez Díaz, Avda. Reyes Católicos, 2, 28040 Madrid, Spain. Email: mruizo{at}fjd.es

Angiotensin II (AngII) participates in the pathogenesis of renal diseases, through the regulation of two key processes inflammation and fibrosis. AT1 and AT2 are the main receptors of AngII. AT1 mediates most of the actions of AngII. This receptor regulates the expression of profibrotic factors, such as connective tissue growth factor (CTGF). The Smad signalling pathway and the Rho/Rho kinase system are two novel mechanisms involved in AngII-induced matrix regulation recently described. The role of AT2 receptors in renal pathophysiological processes is not fully elucidated. Experimental data suggest that AT2 receptors through activation of nuclear factor-{kappa}B participate in renal inflammatory cell recruitment. Studies in animal models of kidney injury have shown that the combined blockade of both AT1 and AT2 receptors, as well as the inhibition of the NF-{kappa}B pathway are necessary to stop the inflammatory process fully. On the whole, these data highlight the complex signalling systems activated by AngII and suggest novel potential targets to block fibrosis and inflammation in renal diseases.

Keywords: angiotensin II; fibrosis; inflammation; proinflammatory cytokines; growth factors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ther Adv Cardiovasc DisHome page
H. Suzuki
Therapeutic efficacy of renin--angiotensin blockade in patients receiving dialysis
Therapeutic Advances in Cardiovascular Disease, October 1, 2009; 3(5): 397 - 405.
[Abstract] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
L. He, Y. Qi, X. Rong, J. Jiang, Q. Yang, J. Yamahara, M. Murray, and Y. Li
The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling
Evid. Based Complement. Altern. Med., August 25, 2009; (2009) nep095v1.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. I. Ager, J. Neo, and C. Christophi
The renin-angiotensin system and malignancy
Carcinogenesis, September 1, 2008; 29(9): 1675 - 1684.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Block, A. Eid, K. K. Griendling, D.-Y. Lee, Y. Wittrant, and Y. Gorin
Nox4 NAD(P)H Oxidase Mediates Src-dependent Tyrosine Phosphorylation of PDK-1 in Response to Angiotensin II: ROLE IN MESANGIAL CELL HYPERTROPHY AND FIBRONECTIN EXPRESSION
J. Biol. Chem., August 29, 2008; 283(35): 24061 - 24076.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
T.-D. Liao, X.-P. Yang, Y.-H. Liu, E. G. Shesely, M. A. Cavasin, W. A. Kuziel, P. J. Pagano, and O. A. Carretero
Role of Inflammation in the Development of Renal Damage and Dysfunction in Angiotensin II-Induced Hypertension
Hypertension, August 1, 2008; 52(2): 256 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. L. Cook, R. N. Re, D. L. deHaro, J. M. Abadie, M. Peters, and J. Alam
The Trafficking Protein GABARAP Binds to and Enhances Plasma Membrane Expression and Function of the Angiotensin II Type 1 Receptor
Circ. Res., June 20, 2008; 102(12): 1539 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
I. Hamming, H. van Goor, A. J. Turner, C. A. Rushworth, A. A. Michaud, P. Corvol, and G. Navis
Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats
Exp Physiol, May 1, 2008; 93(5): 631 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
T. Kisseleva and D. A. Brenner
Fibrogenesis of Parenchymal Organs
Proceedings of the ATS, April 15, 2008; 5(3): 338 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
T. Kisseleva and D. A. Brenner
Mechanisms of Fibrogenesis
Experimental Biology and Medicine, February 1, 2008; 233(2): 109 - 122.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. Sanchez-Lopez, J. Rodriguez-Vita, C. Cartier, M. Ruperez, V. Esteban, G. Carvajal, R. Rodrigues-Diez, J. J. Plaza, J. Egido, and M. Ruiz-Ortega
Inhibitory effect of interleukin-1 on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F149 - F160.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Konigshoff, A. Wilhelm, A. Jahn, D. Sedding, O. V. Amarie, B. Eul, W. Seeger, L. Fink, A. Gunther, O. Eickelberg, et al.
The Angiotensin II Receptor 2 Is Expressed and Mediates Angiotensin II Signaling in Lung Fibrosis
Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 640 - 650.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Gauer, V. Segitz, and M. Goppelt-Struebe
Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3154 - 3159.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Chen, A. M. Guo, P. A. Edwards, G. Trick, and A. G. Scicli
Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1619 - R1629.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. J. Socha, M. Manhiani, N. Said, J. D. Imig, and K. Motamed
Secreted Protein Acidic and Rich in Cysteine Deficiency Ameliorates Renal Inflammation and Fibrosis in Angiotensin Hypertension
Am. J. Pathol., October 1, 2007; 171(4): 1104 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Heeneman, J. C. Sluimer, and M. J.A.P. Daemen
Angiotensin-Converting Enzyme and Vascular Remodeling
Circ. Res., August 31, 2007; 101(5): 441 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Sakai, K. Tamura, Y. Tsurumi, Y. Tanaka, Y. Koide, M. Matsuda, T. Ishigami, M. Yabana, Y. Tokita, Y. Hiroi, et al.
Expression of MAK-V/Hunk in renal distal tubules and its possible involvement in proliferative suppression
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1526 - F1536.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido
TGF-{beta} signaling in vascular fibrosis
Cardiovasc Res, May 1, 2007; 74(2): 196 - 206.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J.-K. Park, R. Fischer, R. Dechend, E. Shagdarsuren, A. Gapeljuk, M. Wellner, S. Meiners, P. Gratze, N. Al-Saadi, S. Feldt, et al.
p38 Mitogen-Activated Protein Kinase Inhibition Ameliorates Angiotensin II-Induced Target Organ Damage
Hypertension, March 1, 2007; 49(3): 481 - 489.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.